Now a cholesterol pill to cut down the risk of a heart attack?

A Monash University trial revealed that Obicetrapib significantly lowered LDL cholesterol by 32.6% and lipoprotein(a) by 33.5% in participants already on maximum tolerated doses of traditional therapies.


View article...


Top stories of the last 30 days

IN06091 — गालूडीह के ग्रामीण इलाकों में मलेरिया का प्रकोप, स्वास्थ्य विभाग अलर्ट